-
admin
Posts
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB) (“IN8bio” or the “Company”), a clinical-stage biopharmaceutical company developing innovative gamma-delta (“γδ”) T...
Aktis Oncology to Present at the BofA Securities Health Care Conference
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) — Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted...
Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours
TORONTO, May 06, 2026 (GLOBE NEWSWIRE) — Brain Cancer Canada, the country’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide, is...
Medical Saunas Celebrates Being Honoured in RetailHub’s Best Custom Saunas of 2026 Roundup
Valencia, CA, May 06, 2026 (GLOBE NEWSWIRE) — Medical Saunas, an industry-recognized leader in premium, fully customizable home saunas, is thrilled to announce that it...
Kaneka Ubiquinol™ Wins Coveted Vitafoods Europe Innovation Award 2026 in Partnership with Eqology
Kaneka Ubiquinol’s ‘Flexibility in Formulation’ innovation partnership philosophy driving world-class award-winning results Ubiquinol-powered Mitochondrial Health moves front and centre across food, nutraceutical and beverage formulations...
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
SUZHOU, China and MÖLNDAL, Sweden, May 6, 2026 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (“Ribo”, HKEX: 6938) today announced...
Lee Kum Kee Launches #FlavorsofAAPI Partnerships
Elevating Asian American Culinary Stories Through Culture, Craft and Self-Discovery LOS ANGELES, May 6, 2026 /PRNewswire/ — Lee Kum Kee announces the launch of AAPI...
(E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression
Preclinical studies have highlighted how (E,E)-bisantrene silences c-MYC gene expression via G4-DNA binding and stabilization leading to clinically relevant and broad anticancer activity SYDNEY, May...
Blaize Announces Pricing of $35 Million Public Offering of Common Stock
EL DORADO HILLS, Calif., May 6, 2026 /PRNewswire/ — Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize,” the “Company,” “we,” “our,” or “us”), a leader...
Bread Financial Announces Pricing of an Offering of Depositary Shares Representing Interests in Its Series B Preferred Stock
COLUMBUS, Ohio, May 05, 2026 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) announced today the pricing of its...
